Careology launched in 2019 to build the world’s leading digital cancer care platform. Founder & CEO Paul Landau takes to the Rewired stage, to talk about the impact digital transformation can have in the cancer care space.
Bringing digital transformation to cancer care is extremely complex, we have spent the last few years researching and developing our product with both patients and clinical teams. Today, the product allows patients to navigate every stage of treatment in a digital-first way, while sharing critical data on symptoms, medications, side effects and more with healthcare teams, and seamlessly connecting to caregivers.
By combining a patient-led approach with a cutting-edge data and technology platform, Careology is empowering people living and dealing with cancer to do more for themselves at home, while allowing clinical and care teams to extend their reach beyond the walls of the hospital.
Careology is bolstering its team for the next stage of growth, with two key appointments. With vast experience in healthcare management across the public and private sector, Danae Dudley-Hammatt joins as Chief Operating Officer. With a background in quality, efficiency and productivity (QEP) management, Danae will be responsible for onboarding future clients and scaling the product and company.
We asked Danae, what are you most excited about in your new role at Careology?
Danae Dudley-Hammatt comments:
"Working with an amazingly driven and knowledgeable team to create a product that has the potential to transform cancer care globally. I am incredibly motivated to improve the healthcare journey and experience of patients who enter the healthcare system at the worst point in their lives. Creating one more #UpDay is enough motivation to get me out of bed in the morning.”
This follows the news in the second half of last year that Careology is now working with leading cancer care providers and private medical insurers such as Guy’s & St Thomas’ NHS Trust, The Royal Marsden Trust, East of England Cancer Alliance, Nuffield Health and Aviva, among others.
Founder & CEO Paul Landau commented:
"We are seeing a fundamental shift in the way healthcare is being delivered; the pandemic fast-tracked the digital revolution that healthcare, and particularly cancer care, has been crying out for. Digital cancer care has the potential to improve efficiency, build clinical capacity, lower the risk of complications and improve outcomes. All while vastly improving the overall patient experience. This is why I am so pleased to welcome Danae & Pip to the team, as we continue to build the world’s leading digital cancer care platform.”
By putting the patient’s needs right at the centre of how the technology is developed, Careology is now consistently selected as the leading digital cancer care app, in terms of functionality, design and ease of use. The development of the product alongside clinical teams has resulted in real clinical rigour that healthcare teams trust. At the end of the last year, an independent white paper reviewed over 400 cancer related applications and Careology came out as number one.
Careology is building the world’s leading digital cancer care platform. By equipping and seamlessly connecting patients, caregivers and healthcare teams in a complex pathway, our mission is to use technology to transform traditional cancer care and change everyone’s cancer story for the better. Today the platform allows patients to manage and navigate all aspects of treatment from their device, while leveraging critical data on symptoms, medications, side effects and more, to deliver insight and analysis to clinical teams through a ‘virtual ward’. By increasing the potential for patients to self-serve, improving workflows, making 24/7 monitoring possible and putting a unique data set to work, we are helping to relieve pressure on health systems, while reducing costs, improving patient and clinician experience, and optimising health outcomes.